Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma.
Green Sb(National Institutes of Health), Strike Ta, Hunt We, P. Paoletti, Brooks Wh, Shapiro Wr, Pistenmaa Da(Radiation Oncology Associates), Joseph Ransohoff, Robertson Jt, Smith Kr, John Mealey, Ulrich Batzdorf(National Institutes of Health), Selker Rg, Odom Gl, E Alexander(Atrium Health Wake Forest Baptist), Wilson Cb, Walker(National Institutes of Health), Byar Dp(National Institutes of Health)
PubMed
February 1, 1983
Cited by 407
Related Papers
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas
|Journal of neurosurgery|1978|1.7k
Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after Surgery
|New England Journal of Medicine|1980|1.6k
Stereotactic Radiosurgery for the Definitive, Noninvasive Treatment of Brain Metastases
|JNCI Journal of the National Cancer Institute|1995|584
Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma
|Journal of neurosurgery|1989|462
The treatment of recurrent brain metastases with stereotactic radiosurgery.
|Journal of Clinical Oncology|1990|296